Antiepileptics other than gabapentin, pregabalin, topiramate, and valproate for the prophylaxis of episodic migraine in adults (Q24201845)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23797674 AND SRC:MED&resulttype=core&format=json

3 March 2020

meta-analysis

0 references

title

Antiepileptics other than gabapentin, pregabalin, topiramate, and valproate for the prophylaxis of episodic migraine in adults (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23797674 AND SRC:MED&resulttype=core&format=json

3 March 2020

0 references

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23797674 AND SRC:MED&resulttype=core&format=json

3 March 2020

Douglas C McCrory

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23797674 AND SRC:MED&resulttype=core&format=json

3 March 2020

author name string

Mattias Linde

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23797674 AND SRC:MED&resulttype=core&format=json

3 March 2020

Edward P Chronicle

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23797674 AND SRC:MED&resulttype=core&format=json

3 March 2020

publication date

24 June 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23797674 AND SRC:MED&resulttype=core&format=json

Cochrane Database of Systematic Reviews

3 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23797674 AND SRC:MED&resulttype=core&format=json

3 March 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23797674 AND SRC:MED&resulttype=core&format=json

3 March 2020

page(s)

CD010608

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23797674 AND SRC:MED&resulttype=core&format=json

Evaluation of carisbamate for the treatment of migraine in a randomized, double-blind trial

3 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1002/14651858.CD010608

Effects of topiramate and levetiracetam vs placebo on habituation of contingent negative variation in migraine patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD010608

Effects of levetiracetam vs topiramate and placebo on visually evoked phase synchronization changes of alpha rhythm in migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD010608

Oxcarbazepine in migraine headache: a double-blind, randomized, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD010608

Clonazepam (rivotril) in migraine prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD010608

Efficacy and tolerability of acetazolamide in migraine prophylaxis: a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD010608

Persistent migrainous visual phenomena might be responsive to lamotrigine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD010608

Levetiracetam as migraine prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD010608

Effectiveness of lamotrigine in the prophylaxis of migraine with aura: an open pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD010608

Lamotrigine in the prophylactic treatment of migraine aura--a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD010608

Double-blind study of belladonna-ergotamine-phenobarbital for interval treatment of recurrent throbbing headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD010608

Economic and social impact of migraine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD010608

Recent progress in anticonvulsant drug research: strategies for anticonvulsant drug development and applications of antiepileptic drugs for non-epileptic central nervous system disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD010608

Impact of migraine and tension-type headache on life-style, consulting behaviour, and medication use: a Canadian population survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD010608

New drugs in migraine treatment and prophylaxis: telcagepant and topiramate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD010608

EFNS guideline on the drug treatment of migraine--revised report of an EFNS task force

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD010608

Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD010608

What is meant by intention to treat analysis? Survey of published randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD010608

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD010608

The cost of headache disorders in Europe: the Eurolight project

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD010608

Topiramate for the prophylaxis of episodic migraine in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD010608

Valproate (valproic acid or sodium valproate or a combination of the two) for the prophylaxis of episodic migraine in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD010608

Gabapentin or pregabalin for the prophylaxis of episodic migraine in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD010608

Self-medication of regular headache: a community pharmacy-based survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD010608

New appendix criteria open for a broader concept of chronic migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD010608

Evidence-based guideline update: pharmacologic treatment for episodic migraine prevention in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD010608

Drugs for preventing migraine headaches in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD010608

Anticonvulsant drugs for acute and chronic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD010608

Anticonvulsant drugs for migraine prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD010608

Anticonvulsants in migraine prophylaxis: a Cochrane review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD010608

A double-blind crossover comparison of the effects of vigabatrin with placebo in the prevention of migraine headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD010608

7 January 2021

Lamotrigine versus placebo in the prophylaxis of migraine with and without aura

1 reference

https://api.crossref.org/works/10.1002/14651858.CD010608

7 January 2021

Zonisamide versus topiramate in migraine prophylaxis: a double-blind randomized clinical trial

1 reference

https://api.crossref.org/works/10.1002/14651858.CD010608

7 January 2021

Guidelines for controlled trials of drugs in migraine: third edition. A guide for investigators

1 reference

https://api.crossref.org/works/10.1002/14651858.CD010608

7 January 2021

10.1002/14651858.CD010608

Identifiers

DOI

2 references

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

3883035

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23797674 AND SRC:MED&resulttype=core&format=json

OpenCitations bibliographic resource ID

3 March 2020

3883035

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

3883035

1 reference